Literature DB >> 15261692

Induction of auto-anti-idiotypic antibodies specific for antibodies to matrix and envelope glycoprotein from pigs experimentally infected with porcine reproductive and respiratory syndrome virus.

En-Min Zhou1, Alfonso Clavijo, Zhengjun Jiang, Mehrdad Ameri-Mahabadi, Jeffrey J Zimmerman.   

Abstract

Auto-anti-idiotypic antibodies (Aab-2s) specific for antibodies against envelope glycoprotein GP5 were previously identified in 10 of 12 pigs experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV). In this study, we report in addition the induction of Aab-2s specific for antibodies against matrix (M) and envelope glycoprotein GP5 antigens in 38 of 47 pigs experimentally infected with PRRSV. Two sets of Aab-2s were induced in the sera, one at 21 days post-infection (DPI) and peaked on 35 DPI and another at 49 DPI and peaked on 77 DPI. The Aab-2s induced at an early stage were from non-virus carrier pigs as defined when they were euthanized on and after 77 DPI. In contrast, the Aab-2s induced at a later stage were from virus carrier pigs. These Aab-2s possessed the characteristics of internal image Ab-2s and recognized shared idiotypes on swine and murine antibodies to the GP5 and M antigens of PRRSV. This study further demonstrates that, during the antibody responses to PRRSV infection, Aab-2s specific for both anti-M and anti-GP5 antibodies were induced. More importantly, the early and late Aab-2s possessed different idiotype-binding specificities. By detecting and characterizing these Aab-2s, it may be possible to identify whether pigs infected with PRRSV will clear the virus or become virus carriers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261692     DOI: 10.1016/j.vetimm.2004.03.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.

Authors:  Ying Yu; Xuehui Cai; Gang Wang; Ning Kong; Yonggang Liu; Yihong Xiao; Chong Zhang; Yang Mu; Shuqi Xiao; Qin Zhao; Chengbao Wang; Gaiping Zhang; Julian A Hiscox; En-Min Zhou
Journal:  BMC Vet Res       Date:  2014-02-08       Impact factor: 2.741

Review 2.  Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Authors:  Yuchen Nan; Chunyan Wu; Guoqian Gu; Weiyao Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.